GlassScriptPhysician profile
Riad A Aboujamous
NPI 1255386058
$4,840.19
in general payments reported to CMS, 2019-2025
18 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $648 · 2022: $1,690 · 2023: $529 · 2024: $1,474 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $795.53 | 2021-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $737.99 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $573.56 | 2022-2025 | |
| Novo Nordisk INC | $511.48 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $398.64 | 2021-2025 | Jardiance |
| Esperion Therapeutics, INC. | $350.86 | 2021-2024 | Nexletol |
| Amgen INC. | $202.76 | 2021-2024 | Repatha, Otezla |
| Corcept Therapeutics | $201.42 | 2024-2025 | Korlym |
| Abbott Laboratories | $192.93 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $181.75 | 2022 | |
| Abbvie INC. | $174.07 | 2021-2025 | Ubrelvy |
| Redhill Biopharma INC. | $130.30 | 2021-2023 | Talicia |
| Phathom Pharmaceuticals, INC. | $110.40 | 2024 | Voquezna |
| Pfizer INC. | $73.53 | 2023-2024 | |
| Genentech USA, INC. | $71.50 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $59.25 | 2021-2022 | |
| Exact Sciences Corporation | $39.00 | 2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $35.22 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riad Aboujamous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.